Canadian Pacific Kansas City Ltd. Stock Falls Wednesday, Underperforms Market
Dow Jones2026/10/28 20:31This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Canadian Pacific Kansas City Ltd. CP slid 1.79% to C$125.70 Wednesday, in what proved to be an otherwise all-around favorable trading session for the Canadian market, with the S&P/TSX Composite Index rising 0.26% to 36,265.09.
Canadian Pacific Kansas City Ltd. closed 5.8% short of its 52-week high of C$133.38, which the company achieved on August 21st.
Trading volume of 1.0 M shares remained below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 28, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 28, 2026 16:31 ET (20:31 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs comments on AMD (AMD.US) Q3 performance: Data center CPU and GPU show strong performance, growth visibility for 2027 is clear
Goldman Sachs released a research report maintaining a "Buy" rating on AMD (AMD.US) with a 12-month target price of $675.

A recorder hidden in toilet paper exposes OpenAI's long-standing safety issues

AbbVie (ABBV.US) expands Oxford R&D facility in UK, betting on innovation in immunology, neuroscience, and oncology drugs
AbbVie announced on Wednesday that, as part of an investment plan exceeding 120 million pounds (approximately $161 million), the company has expanded its research and development facility in Oxford, United Kingdom.